Affymax (OTCMKTS:AFFY) Stock Passes Above 200 Day Moving Average – What’s Next?

Affymax Inc. (OTCMKTS:AFFY)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0013. Affymax shares last traded at $0.0013, with a volume of 1,000 shares traded.

Affymax Stock Performance

About Affymax

Affymax, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare and underserved diseases. The company leverages its proprietary TransCon® drug delivery platform to create prodrugs that offer sustained, predictable release of active pharmaceutical ingredients. Affymax’s research efforts concentrate on endocrinology and nephrology indications, seeking to address conditions that currently have limited treatment options.

Among its lead product candidates, Affymax is advancing TransCon® PTH for the treatment of hypoparathyroidism and TransCon® Growth Hormone (TransCon® GH) for pediatric growth hormone deficiency.